Neumora Therapeutics, Inc.
Q4 2024 13F Holders
Symbol
NMRA
CUSIP
640979100
Type
Equity
Class
COM
Num filings
166
Total reported value, excl. options
$852 M
Compare 2024 Q4 to
2025 Q1
2024 Q3
2024 Q2
2024 Q1
2023 Q4
2023 Q3
Manager
Report Date
Value ($000)
Shares
Option Type